Boston Scientific Corporation
corporate_fare Company Profile
Boston Scientific Corporation (NYSE:BSX) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 45 items for BSX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-20, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 9 rated 8 or above. Recent SEC coverage for BSX spans 8-K, FWP, 424B5, 10-Q.
Recent high-impact activity:
- Boston Scientific Prices $3.0B and €4.25B Senior Notes to Fund Penumbra Deal
- Boston Scientific Prices $3.0B Four-Tranche Senior Notes to Fund Penumbra Deal
- Boston Scientific Prices €4.25B Six-Tranche Euro Notes to Fund Penumbra Deal
- Boston Scientific Markets Four-Series USD Senior Notes to Fund $14.5B Penumbra Deal
- Boston Scientific Unit Launches Multi-Tranche Euro Notes to Fund $14.5B Penumbra Deal
Financial Snapshot
Short Interest & Short Volume
1.65 days to coverFINRA reported short interest of 35,113,858 shares in BSX as of the October 30, 2026 settlement, a 13.7% decrease from the prior period — about 1.6 days to cover at its recent average daily volume. On November 20, 2026, 39.0% of BSX volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Recent Capital Actions
-
2026-02-27 Proposed Mixed Merger +43.85M sh
-
2026-02-26 Executed Long-term debt ↓ −$3.27B (net of 7 line items)
-
2026-02-26 Executed Total debt ↓ −$3.27B (net of 7 line items)